044. COVID-19: Complications, Coinfections and Clinical Outcomes: Thursday, 12:15 - 1:30 p.m.
Poster Session: COVID-19: Complications, Coinfections and Clinical Outcomes
Lindsay E. Clegg, PhD (she/her/hers)
Associate Director, Clinical Pharmacology and Pharmacometrics
AstraZeneca
Gaithersburg, Maryland, United States
Oleg Stepanov, MS
AstraZeneca
Cambridge, England, United Kingdom
Henning Schmidt, PhD
IntiQuan GmBH
Basel, Basel-Stadt, Switzerland
Ventakesh Pilla Reddy, PhD
AstraZeneca
Cambridge, England, United Kingdom
Weifeng Tang, MD, PhD
AstraZeneca
Gaithersburg, Maryland, United States
Michael Gibbs, PhD
AstraZeneca
Cambridge, England, United Kingdom
Sangeeta Sedani, MSc
AstraZeneca
Cambridge, England, United Kingdom
Antonella Nadia Tuillio, MD
AstraZeneca
Gaithersburg, Maryland, United States
Sam Sadow, MA
AstraZeneca
Gaithersburg, Maryland, United States
Nuria Martinez-Alier, PhD
AstraZeneca
Cambridge, England, United Kingdom
Taylor Cohen, PhD
Global Project Lead
AstraZeneca
Gaithersburg, Maryland, United States
Saul N. Faust, FRCPCH PhD (he/him/his)
Professor of Paediatric Immunology and Infectious Diseases
University of Southampton and University Hospital Southampton NHS Foundation Trust
Southampton, England, United Kingdom
Mark T. Esser, PhD
Phylogenetic and alpha toxin variant analyses of Staphylococcus aureus strains isolated from patient
AstraZeneca
Gaithersburg, Maryland, United States
Mats Någård, PhD
AstraZeneca
Gaithersburg, Maryland, United States